SEC Form 4 · accession 0001615774-17-007195
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey E. Harris
Director
Period of report
Dec 5, 2017
Accepted (ET)
Dec 7, 2017 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 5, 2017 | P | 52 | $3.60 | A | 47,610 | D | |
| Common Stock | Dec 6, 2017 | P | 1,000 | $3.85 | A | 48,610 | D | |
| Common Stock | Dec 6, 2017 | P | 3,500 | $3.80 | A | 52,110 | D |
Table II — derivative securities
No Table II lines on this filing.